| GKOS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the GKOS shares outstanding history going back to 6/25/2015:
Also see: GKOS Market Cap History GKOS YTD Return |
GKOS Shares Outstanding History — Glaukos Share Count Over Time
As of 4/28/2026 Glaukos has 58.73 million GKOS shares outstanding. Investors often track the GKOS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows GKOS share count trends over time, with 45 historical shares outstanding datapoints presented, dating back to 6/25/2015.
| GKOS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GKOS Historical Shares Outstanding: +6.27% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GKOS Stock Price Chart |
| About Glaukos Corp |
| Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company developing dropless therapies for glaucoma, corneal disorders, and retinal disease. Its products include Micro-Invasive Glaucoma Surgery devices to reduce intraocular pressure by restoring natural aqueous humor outflow, intracameral drug delivery technologies for sustained glaucoma medication, transdermal pharmaceuticals for glaucoma, dry eye, presbyopia, and other ocular diseases, and bio-erodible sustained release drug delivery implants to improve vision. We show 45 historical shares outstanding datapoints in our coverage of GKOS's shares outstanding history. Understanding the changing numbers of GKOS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GKOS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GKOS by allowing them to research GKOS shares outstanding history as well as any other stock in our coverage universe. |
| GKOS Current Stock Quote |
Quotes delayed 20 minutes  Free GKOS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| GKOS Share Performance |
| Shares Outstanding Peers |
| Glaukos (GKOS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GLSI Shares Outstanding History GLTO Shares Outstanding History GLUE Shares Outstanding History GLXY Shares Outstanding History GLYC Shares Outstanding History GMED Shares Outstanding History GMTX Shares Outstanding History GNCA Shares Outstanding History GNLX Shares Outstanding History GNMK Shares Outstanding History More Healthcare companies » |
GKOS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
